Chapter 436 - 262: International Hepatitis B Primary Liver Cancer Treatment Research Group
Chapter 436: Chapter 262: International Hepatitis B Primary Liver Cancer Treatment Research Group
The International Liver Cancer Association is the sole international organization dedicated to the research of liver cancer and related disciplines. It brings together scientists, doctors, and dedicated professionals from around the world to advance the understanding of liver cancer’s pathogenesis, as well as its prevention and treatment.
The association’s leadership included roles like honorary president, president, secretary-general, vice president, and executive director. The president was Professor Edwards, the Vice Dean of the University of Texas MD Anderson Cancer Center.
Jin Country also had many scientists and doctors who were members of this association.
Han Shun, Director of Hepatic Tumor Surgery 02 in Qinghe City, was an executive director of the International Liver Cancer Association.
Director Han was very interested in this "Neutrino" therapy device. After receiving the invitation, he decided to travel to the Southern Country to attend the conference.
Director Han and Dean Chen of the Xianglin City Xuanshang University Affiliated Tumor Hospital were classmates. After receiving the invitation, he contacted Dean Chen directly.
"Old Chen, Professor Edwards has teamed up with the University of California, Berkeley Department of Physics and Ruihui Pharmaceutical. They’ve developed a brand-new instrument—a neutrino collider for treating HBV-related primary liver cancer."
"What do you say? Are you interested in attending the conference together? We could talk to Professor Edwards about a collaboration, bring the world’s most advanced device for treating HBV-related primary liver cancer into the country, and be the pioneers."
Han Shun was well-versed in both Eastern and Western medicine and had always been at the forefront of academia. He held an open and inclusive attitude toward collaborating with top international institutions.
In his view, this revolutionary product was an excellent opportunity.
It was impossible for Chen Bofeng to be uninterested in the Neutrino therapy device. However, according to its description, it was a non-invasive treatment for HBV-related primary liver cancer, and for now, it was limited to the early-to-mid stages. Furthermore, it wasn’t a cure. It could only control the body’s viral load and alleviate symptoms through regular treatments.
Moreover, the device was powerless against late-stage liver cancer, capable only of providing localized symptom relief.
Before he came into contact with Wu Ting’s research project, Dean Chen would have certainly praised it endlessly, marveling at how incredible this non-invasive technology was.
Being able to slow and control the progression of HBV-related primary liver cancer was already a particularly remarkable achievement!
However, Wu Ting’s research had shown Dean Chen the possibility of a complete cure—a systematic curative technology for stages one through four. The two were on completely different levels!
He had already arranged an intensive training session with Wu Ting’s team this month. After some thought, Dean Chen directly rejected Director Han’s invitation.
"Old Han, I’m sure you’ve been following the plans and research of our hepatic tumor research center. Our team is holding an internal training session this month, so I won’t be going to the Southern Country."
"Our four hospitals have now formed a pilot group to focus all our efforts on our own innovative new technology. In terms of the project’s ultimate vision, I’m more optimistic about our own team’s project."
Dean Chen had already gone all-in on Wu Ting’s project, so he didn’t hold back in expressing his determination to support Wu Ting’s independent research and development to Han Shun.
Hearing Dean Chen’s words, Han Shun was a bit confused and also felt it was a pity.
"That’s a real shame. Bo Feng, I think by not attending this grand event, you’re going to miss a historic moment in the treatment of HBV-related primary liver cancer!"
"Professor Edwards’s therapeutic concept for this neutrino collider device is unprecedented. A non-invasive treatment like this is truly imaginative and showcases the allure of technology. It might have many limitations and flaws right now, but once this conference is over, Professor Edwards will invite scientists, doctors, and institutions from all over the world to join this grand plan. By pooling their wisdom and continuously iterating, it’s very possible they could truly solve the problem of diagnosing and treating HBV-related primary liver cancer!"
After expressing his thoughts, Han Shun said no more. He knew that once Chen Bofeng made a decision, he was as stubborn as a mule.
"Alright, Bo Feng, you go ahead and attend your training session here in the country. When I get back from the conference, I’ll share the latest concepts and ideas from the event with you."
While Chen Bofeng, Fu Jinfen, and others were undergoing their intensive training with Wu Ting at City First Hospital, many experts and professors from within the country set off for the Southern Country.
Professor Ma Mengchao from Jiuhua Hospital, a professor from Yacheng Hospital, a professor from Xianglin City Transportation University Affiliated Ruijin Hospital, a professor from Qinghe City You’an Hospital, a professor from Qinghe City Ditan Hospital, and others all set out for this international grand event.
It had to be said that the research achievement led by Professor Edwards was on a completely different track, something that went far beyond anyone’s imagination!
「On the day of the conference.」
Aside from the invited medical experts from all over the world, there were also representatives from major pharmaceutical companies, members of the media, and many patients who had come hoping to secure a spot as a volunteer.
Inside the huge lecture hall of the University of Texas MD Anderson Cancer Center, amidst the enthusiastic cheers of representatives from all sectors, the entire research team for the Neutrino project took the stage!
The team’s leader, Professor Edwards, made a suave entrance. As the Vice Dean of the University of Texas MD Anderson Cancer Center and the President of the International Liver Cancer Association, Edwards was world-renowned. He was frequently invited to various international academic events and had a large following of supporters and fans.
Even back home, many experts considered Professor Edwards their idol!